Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.

Kidney international - 1 Feb 2004

Kronenberg Florian, Lingenhel Arno, Lhotta Karl, Rantner Barbara, Kronenberg Martina F, König Paul, Thiery Joachim, Koch Michael, von Eckardstein Arnold, Dieplinger Hans

Abstract excerpt

BACKGROUND: The atherogenic serum lipoprotein(a) [Lp(a)] is significantly elevated in patients with nephrotic syndrome. The underlying mechanism for this elevation is poorly understood. METHODS: We investigated in 207 patients with nondiabetic nephrotic syndrome and 274 controls whether the apolipoprotein(a) [apo(a)] kringle-IV repeat polymorphism explains the elevated Lp(a) levels in these patients. RESULTS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins A
Share to Arteriosclerosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to SDS gene

Share to Lipoproteins and Cardiovascular Health

Share to Nephrotic Syndrome

Share to Phenotype

Share to Polymorphism, Genetic

Share to Renal Diseases and Glomerulopathies

Source

Identifiers

PMID: 14717931
DOI: 10.1111/j.1523-1755.2004.00418.x

Genes

SDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.PMID 14717931Read ↗

Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.Semantic proximity Read ↗

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).Semantic proximity Read ↗

Apolipoprotein L1 nephropathies: 2017 in review.Semantic proximity Read ↗

Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.Semantic proximity Read ↗

Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.Semantic proximity Read ↗

Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.Semantic proximity Read ↗

Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.Semantic proximity Read ↗

Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.Semantic proximity Read ↗

The atherogenic lipoprotein phenotype in renal diseaseSemantic proximity Read ↗

Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.Semantic proximity Read ↗

Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era.Semantic proximity Read ↗

Is dyslipidemia sustained during remission of nephrotic syndrome genetically determined? Evaluation of genetic polymorphisms of proteins involved in lipoprotein metabolism in children and adolescents with nephrotic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.